U.S. markets close in 3 hours 22 minutes

VolitionRx Limited (VNRX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
2.3850+0.0550 (+2.36%)
As of 12:10PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.3300
Bid2.3500 x 1000
Ask2.4200 x 1000
Day's Range2.3400 - 2.4400
52 Week Range2.0800 - 4.1400
Avg. Volume76,019
Market Cap151.581M
Beta (5Y Monthly)1.65
PE Ratio (TTM)N/A
EPS (TTM)-0.5310
Earnings DateAug 09, 2022 - Aug 15, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for VNRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • VolitionRX Limited
    Analyst Report: Abbott LaboratoriesAbbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
    Fair Value
    Economic Moat
    17 days agoMorningstar
View more
  • PR Newswire

    VolitionRx Limited Announces First Quarter 2022 Financial Results and Business Update

    VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the first quarter ended March 31, 2022. Volition management will host a conference call tomorrow, May 12 at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details can be found below.

  • PR Newswire

    VolitionRx Limited Schedules First Quarter 2022 Earnings Conference Call and Business Update

    VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Thursday May 12, at 08.30 a.m. Eastern Time to discuss its financial and operating results for the first quarter 2022, in addition to providing a business update. Volition previously announced it will host a Capital Markets Day at the New York Stock Exchange on Friday May 13, details of said event can also be found below.

  • PR Newswire

    VolitionRx Limited to Host Capital Markets Day on Friday May 13

    VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") a multi-national epigenetics company plans to host a Capital Markets Day in a hybrid format on Friday, May 13, 2022, at 10 a.m. U.S. Eastern Time. Volition's executive team will provide strategic updates and discuss the Company's key short-term growth drivers.